Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹1000 | ₹500 |
Expense Ratio | 1.77 | 1.72 |
NAV | ₹211.31 | ₹185.06 |
Fund Started | 12 Feb 2001 | 15 Feb 2007 |
Fund Size | ₹8525.04 Cr | ₹10007.39 Cr |
Exit Load | Exit load of 0.50% if redeemed within 3 months. | Exit load for units in excess of 10% of the investment, 1% will be charged for redemption within 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -6.96% | 6.69% |
3 Year | 14.27% | 25.95% |
5 Year | 23.42% | 25.11% |
1 Year
3 Year
5 Year
Equity | 90.52% | 99.43% |
Cash | 6.68% | 0.57% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Tata Communications Ltd. | 8.72% |
Aurobindo Pharma Ltd. | 7.97% |
Premier Energies Ltd. | 7.11% |
IRB Infrastructure Developers Ltd. | 6.71% |
Nifty MidCap Select Index | 5.66% |
Lloyds Metals & Energy Ltd. | 5.62% |
Reliance Industries Ltd. | 5.38% |
GMR Airports Ltd. | 5.00% |
Lupin Ltd. | 4.93% |
Linde India Ltd. | 3.38% |
Name | Assets |
|---|---|
AU Small Finance Bank Ltd. | 5.59% |
Swiggy Ltd. | 5.23% |
The Federal Bank Ltd. | 5.07% |
L&T Finance Ltd. | 4.89% |
Prestige Estates Projects Ltd. | 4.59% |
BSE Ltd. | 4.04% |
Max Financial Services Ltd. | 4.02% |
Glenmark Pharmaceuticals Ltd. | 3.78% |
Sai Life Sciences Ltd. | 3.30% |
JK Cement Ltd. | 3.19% |
Name | Ankit A Pande | Amit Ganatra |
Start Date | 07 Jul 2025 | 03 Oct 2025 |
Name
Start Date
Description | The scheme aims at providing long term capital appreciation and generating income with a diversified portfolio of Mid Cap companies. | The scheme seeks to generate capital appreciation by investing predominantly in Midcap companies |
Launch Date | 12 Feb 2001 | 15 Feb 2007 |
Description
Launch Date